➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Mallinckrodt
Colorcon
McKesson
Moodys

Last Updated: January 20, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Magnesium gluconate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Magnesium gluconate?

Magnesium gluconate is an investigational drug.

There have been 10 clinical trials for Magnesium gluconate. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2020.

The most common disease conditions in clinical trials are Neurotoxicity Syndromes, Colorectal Neoplasms, and Peripheral Nervous System Diseases. The leading clinical trial sponsors are National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, and University of Alberta.

There are seven hundred and forty-nine US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Magnesium gluconate
TitleSponsorPhase
The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients.Medical Universtity of LodzPhase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGAWoman'sPhase 4
Low Dose Magnesium Sulphate Versus Standard Pritchard Regimen In Management Of Severe Preeclampsia/EclampsiaAdebayo Joshua AdeniyiN/A

See all Magnesium gluconate clinical trials

Clinical Trial Summary for Magnesium gluconate

Top disease conditions for Magnesium gluconate
Top clinical trial sponsors for Magnesium gluconate

See all Magnesium gluconate clinical trials

US Patents for Magnesium gluconate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Magnesium gluconate   Start Trial Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome ANTECIP BIOVENTURES II LLC (New York, NY)   Start Trial
Magnesium gluconate   Start Trial Dialysis formulation GAMBRO LUNDIA AB (Lund, SE)   Start Trial
Magnesium gluconate   Start Trial Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Magnesium gluconate

Drugname Country Document Number Estimated Expiration Related US Patent
Magnesium gluconate Australia AU2013262995 2032-05-14   Start Trial
Magnesium gluconate Australia AU2014340649 2032-05-14   Start Trial
Magnesium gluconate Australia AU2015267046 2032-05-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Mallinckrodt
Colorcon
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.